Health2 days ago
Enterprise Therapeutics’ ETD001 Shows Promise in Cystic Fibrosis Trial
Enterprise Therapeutics Ltd has published significant findings from its Phase 1 trial of ETD001, a novel inhaled epithelial sodium channel (ENaC) blocker aimed at treating cystic...